At the molecular level, the main mutations in ALM and non-ALM are similar (they include mutations in the BRAF, NRAS, NF1 and KIT genes) but the prevalence differs (Moon et al., 2018; Zebary et al., 2013). The gene discussed is NRAS; the disease is acral lentiginous melanoma.